Chronic Ethanol Consumption in Rats Produces Opioid Antinociceptive Tolerance through Inhibition of Mu Opioid Receptor Endocytosis

被引:23
作者
He, Li [1 ]
Whistler, Jennifer L. [1 ,2 ]
机构
[1] Univ Calif, Ernest Gallo Clin & Res Ctr, Emeryville, CA USA
[2] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA
关键词
ALCOHOL DEPENDENCE; MORPHINE-TOLERANCE; CROSS-TOLERANCE; SPINAL-CORD; INTRATHECAL MORPHINE; NUCLEUS-ACCUMBENS; BETA-ENDORPHIN; KNOCKOUT MICE; BRAIN; DESENSITIZATION;
D O I
10.1371/journal.pone.0019372
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
It is well known that the mu-opioid receptor (MOR) plays an important role in the rewarding properties of ethanol. However, it is less clear how chronic ethanol consumption affects MOR signaling. Here, we demonstrate that rats with prolonged voluntary ethanol consumption develop antinociceptive tolerance to opioids. Signaling through the MOR is controlled at many levels, including via the process of endocytosis. Importantly, agonists at the MOR that promote receptor endocytosis, such as the endogenous peptides enkephalin and beta-endorphin, show a reduced propensity to promote antinociceptive tolerance than do agonists, like morphine, which do not promote receptor endocytosis. These observations led us to examine whether chronic ethanol consumption produced opioid tolerance by interfering with MOR endocytosis. Indeed, here we show that chronic ethanol consumption inhibits the endocytosis of MOR in response to opioid peptide. This loss of endocytosis was accompanied by a dramatic decrease in G protein coupled receptor kinase 2 (GRK2) protein levels after chronic drinking, suggesting that loss of this component of the trafficking machinery could be a mechanism by which endocytosis is lost. We also found that MOR coupling to G-protein was decreased in ethanol-drinking rats, providing a functional explanation for loss of opioid antinociception. Together, these results suggest that chronic ethanol drinking alters the ability of MOR to endocytose in response to opioid peptides, and consequently, promotes tolerance to the effects of opioids.
引用
收藏
页数:8
相关论文
共 52 条
[1]  
Allen RM, 2000, J PHARMACOL EXP THER, V295, P1012
[2]   Combined pharmacotherapies and behavioral interventions for alcohol dependence - The COMBINE study: A randomized controlled trial [J].
Anton, RF ;
O'Malley, SS ;
Ciraulo, DA ;
Cisler, RA ;
Couper, D ;
Donovan, DM ;
Gastfriend, DR ;
Hosking, JD ;
Johnson, BA ;
LoCastro, JS ;
Longabaugh, R ;
Mason, BJ ;
Mattson, ME ;
Miller, WR ;
Pettinati, HM ;
Randall, CL ;
Swift, R ;
Weiss, RD ;
Williams, LD ;
Zweben, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (17) :2003-2017
[3]   Naltrexone effects on alcohol consumption in a clinical laboratory paradigm: temporal effects of drinking [J].
Anton, RF ;
Drobes, DJ ;
Voronin, K ;
Durazo-Avizu, R ;
Moak, D .
PSYCHOPHARMACOLOGY, 2004, 173 (1-2) :32-40
[4]   How to Design an Opioid Drug That Causes Reduced Tolerance and Dependence [J].
Berger, Amy Chang ;
Whistler, Jennifer L. .
ANNALS OF NEUROLOGY, 2010, 67 (05) :559-569
[5]   A pervasive mechanism for analgesia: Activation of GIRK2 channels [J].
Blednow, YA ;
Stoffel, M ;
Alva, H ;
Harris, RA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (01) :277-282
[6]   Effects of selective opioid receptor antagonists on alcohol-induced and nicotine-induced antinociception [J].
Campbell, Vera Combs ;
Taylor, Robert Emory ;
Tizabi, Yousef .
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2007, 31 (08) :1435-1440
[7]   Distinct domains of the μ-opioid receptor control uncoupling and internalization [J].
Celver, J ;
Xu, M ;
Jin, WZ ;
Lowe, J ;
Chavkin, C .
MOLECULAR PHARMACOLOGY, 2004, 65 (03) :528-537
[8]  
Chen F, 2000, J PHARMACOL EXP THER, V293, P159
[9]   Characterization of the mu and delta opioid receptors in the brain of the C57BL/6 and DBA/2 mice, selected for their differences in voluntary ethanol consumption [J].
deWaele, JP ;
Gianoulakis, C .
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 1997, 21 (04) :754-762
[10]  
DEWAELE JP, 1995, J PHARMACOL EXP THER, V275, P518